Ambu A/S (CPH:AMBU.B)
81.20
+2.60 (3.31%)
Oct 30, 2026, 4:59 PM CET
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 21.2 billion as of October 30, 2026. It is the 4,893rd most valuable company in the world and the 26th biggest in Denmark. Its market cap has decreased by 23.56% in one year.
Market Cap
21.20B
Enterprise Value
21.07B
Revenue
6.24B
Global Rank
Country Rank
#26 Denmark
PE Ratio
42.30
ChartMarket Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 21.20B, an increase of 7,208.32%. That is a compound annual growth rate of 14.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 21.20B | -9.48% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.18T |
| Genmab | 233.76B |
| Coloplast | 108.60B |
| Demant | 77.06B |
| ALK-Abelló | 55.03B |
| H. Lundbeck | 53.17B |
| Bavarian Nordic | 18.58B |
| Zealand Pharma | 15.95B |